Amgen (NASDAQ: AMGN) EVP Reese awarded RSUs, stock options and withholds shares for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amgen Inc. executive David M. Reese reported routine equity compensation awards and a small tax-related share disposition. He received 2,912 shares of Common Stock as a grant on May 5, 2026, including 415 Dividend Equivalents, under Amgen’s Equity Incentive Plan. These Restricted Stock Units vest in four equal annual installments of 25% starting on May 5, 2027, with proration based on completed months of active employment in 2026, and will be settled in common shares on a one-to-one basis. He was also granted 19,002 non-qualified stock options at an exercise price of $329.59 per share, vesting in four equal annual installments of 25% beginning on May 5, 2027 and expiring on May 5, 2036. On May 6, 2026, 454 shares of Common Stock were disposed of at $329.59 per share to cover tax obligations, leaving him with 42,812 Common shares held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
REESE DAVID M
Role
EVP & Chief Technology Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 454 | $329.59 | $150K |
| Grant/Award | Nqso (Right to Buy) | 19,002 | $329.59 | $6.26M |
| Grant/Award | Common Stock | 2,912 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 42,812 shares (Direct, null);
Nqso (Right to Buy) — 19,002 shares (Direct, null)
Footnotes (1)
- The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027, subject to proration based on the number of completed months of active employment in 2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 415 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027, subject to proration based on the number of completed months of active employment in 2026.
Key Figures
RSU grant: 2,912 shares
Dividend Equivalents: 415 shares
Stock options granted: 19,002 options
+4 more
7 metrics
RSU grant
2,912 shares
Restricted Stock Units granted May 5, 2026
Dividend Equivalents
415 shares
Included in RSU grant under Equity Incentive Plan
Stock options granted
19,002 options
Non-qualified stock options granted May 5, 2026
Option exercise price
$329.59 per share
Strike price for 19,002 non-qualified stock options
Option expiration
May 5, 2036
Expiration date of non-qualified stock options
Tax-withheld shares
454 shares
Shares withheld at $329.59 on May 6, 2026 for taxes
Shares held after transactions
42,812 shares
Direct Amgen common stock holdings after tax withholding
Key Terms
Restricted Stock Units (RSUs), Dividend Equivalents (DEs), Equity Incentive Plan, non-qualified stock options, +1 more
5 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 415 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan"
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan)"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
non-qualified stock options financial
"These non-qualified stock options were granted pursuant to the Equity Incentive Plan"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
tax-withholding disposition financial
"transaction_action: "tax-withholding disposition" for 454 Common Stock shares"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
FAQ
What equity awards did Amgen (AMGN) grant to EVP David Reese?
Amgen granted David Reese 2,912 Common shares as Restricted Stock Units and 19,002 non-qualified stock options at $329.59 per share. Both awards were made under the company’s Equity Incentive Plan and represent routine executive compensation.
How do David Reese’s new Amgen (AMGN) RSUs vest and pay out?
The 2,912 RSUs granted to David Reese vest in four equal 25% annual installments starting May 5, 2027. Vested RSUs are paid in Amgen common stock on a one-to-one basis, providing share-based compensation over several years.
What are the terms of David Reese’s new Amgen stock options?
David Reese received 19,002 non-qualified stock options with a $329.59 exercise price, vesting in four equal 25% annual installments starting May 5, 2027. The options expire on May 5, 2036, giving him a long exercise window.
What are Dividend Equivalents in David Reese’s Amgen RSU grant?
The RSU grant includes 415 Dividend Equivalents (DEs), which are additional credits tied to dividends on unvested RSUs. DEs are credited to the RSUs and paid in Amgen common shares on a one-to-one basis, plus cash for any remaining fractional share amount.